The genetic predisposition to produce high levels of TGF-β1 impacts on the severity of eclampsia/pre-eclampsia

References

• Roberts JM, Taylor RN, Musci TJ, Rodgers DM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertension 1991; 4: 700–8
   PubMed Web of Science ®Google Scholar
• Roberts JM, Redman CWR. Pre-eclampsia: more than PIH. Lancet 1993; 341: 1447–51
   PubMed Web of Science ®Google Scholar
• Robertson W B, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. 1967 J Pathol Bacteriol 581–92.
   Google Scholar
• Lim K-H, Zhou Y, Janatpour M, McMaster M, Bass K, Chun S-H, et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997; 151: 1809–18
   PubMed Web of Science ®Google Scholar
• Wilczynski JR, Tchorzewski H, Glowacka E, Banasik M, Lewkowicz P, Szpakowski M, et al. Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm 2002; 11: 105–11
   PubMed Web of Science ®Google Scholar
• Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37: 240–9
   PubMed Web of Science ®Google Scholar
• Hutchinson IV, Turner DM, Sankaran D, Awad MR, Sinnott PJ. Influence of cytokine genotypes on allograft rejection. Transplant Proc 1998; 30: 862–3
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005; 331: 87710
   Web of Science ®Google Scholar
• Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW. A sister's risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol 2005; 193: 965–72
   PubMed Web of Science ®Google Scholar
• Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104: 154–9
   PubMed Web of Science ®Google Scholar
• Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol 2006; 55: 130–5
   PubMed Web of Science ®Google Scholar
• Kaiser T, Grehan M, Brennecke SP, Moses EK. Association of the TNF2 allele with eclampsia. Gynecol Obstet Invest 2004; 57: 204–9
   PubMed Web of Science ®Google Scholar
• Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M. Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia. Mol Hum Reprod 2005; 11: 437–40
   PubMed Web of Science ®Google Scholar
• de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun 2004; 5: 313–4
   PubMed Web of Science ®Google Scholar
• Heffler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1β gene cluster and preeclampsia. Obstet Gynecol 2001; 97: 664–8
   PubMed Web of Science ®Google Scholar
• Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC, et al. Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy. J Hypertens 2005; 23: 2187–91
   PubMed Web of Science ®Google Scholar
• Graham CH, Lala PK. Mechanism of control of trophoblast invasion in situ. J Cell Physiol 1991; 148: 228–34
   PubMed Web of Science ®Google Scholar
• Caniggia I, Letarte M, Post M, Lye SJ. Regulation of trophoblast differentiation by TGF-1 and TGF-3 via endoglin. Placenta 1996; 17: A36
   Google Scholar
• Lala K, Lysiak JJ. Role of locally produced growth factors in human placental growth and invasion with special reference to transforming growth factors. Immunobiology of Reproduction, JS Hunt. Springer-Verlag, New York 1994; 57–81
   Google Scholar
• Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localisation of transforming growth factor-beta at the human fetal–maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992; 46: 561–72
   PubMed Web of Science ®Google Scholar
• Morrish DW, Bhardwaj D, Paras MT. Transforming growth factor β1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology 1991; 129: 22–6
   PubMed Web of Science ®Google Scholar
• Luo S, Yu H, Wu D, Peng C. Transforming growth factor-β1 inhibits steroidogenesis in human trophoblast cells. Mol Hum Reprod 2002; 8: 318–25
   PubMed Web of Science ®Google Scholar
• Bielecki DA, Klonowska-Dziatkiewicz E, Jarocki S, Urban J. Growth factors in pregnancy complications with preeclampsia. Ginekol Pol 2002; 73: 422–9
   PubMedGoogle Scholar
• Benian A, Madazli R, Aksu F, Uzun H, Aydin S. Plasma and placental levels of interleukine-10, transforming growth factor-beta 1, and epithelial-cadherin in preeclampsia. Obstet Gynecol 2002; 100: 327–31
   PubMed Web of Science ®Google Scholar
• Enquobahrie DA, Williams MA, Qiu C, Woelk GB, Mahomed K. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women. J Matern Fetal Neonatal Med 2005; 17: 343–8
   PubMed Web of Science ®Google Scholar
• Muy-Rivera M, Sanchez SE, Vadachkoria S, Qiu C, Bazul V, Williams MA. Transforming growth factor-beta1 (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am J Hypertens 2004; 17: 334–8
   PubMed Web of Science ®Google Scholar
• Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797–802
   PubMed Web of Science ®Google Scholar
• Naicker T, Khedun SM, Moodley J. Transforming growth factor beta levels in platelet depleted plasma in African women with pre-eclampsia. J Obstet Gynaecol 2002; 22: 279–82
   PubMedGoogle Scholar
• Ayatollahi M, Geramizadeh B, Samsami A. Transforming growth factor beta-1 influence on fetal allografts during pregnancy. Transplant Proc 2005; 37: 4603–4
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642–9
   PubMed Web of Science ®Google Scholar
• Laviades C, Varo N, Diez J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 2000; 36: 517–22
   PubMed Web of Science ®Google Scholar
• Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, et al. Transforming growth factor-β 1 hyperexpression in African–American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 2000; 97: 3479–84
   PubMed Web of Science ®Google Scholar
• Russo LM, Osicka TM, Bonnet F, Jerums G, Comper WD. Albuminuria in hypertension is linked to altered lysosomal activity and TGF-beta 1 expression. Hypertension 2002; 39: 281–6
   PubMed Web of Science ®Google Scholar
• Derhaschnig U, Shehata M, Herkner H, Bur A, Woisetschlager C, Laggner AN, et al. Increased levels of transforming growth factor-beta 1 in essential hypertension. Am J Hypertens 2002; 15: 207–11
   PubMed Web of Science ®Google Scholar
• Noble NA, Border WA. Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?. Sem Nephrol 1997; 17: 455–66
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996; 49: 461–9
   PubMed Web of Science ®Google Scholar
• Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β 1 gene polymorphisms. Transpl Immunol 1999; 7: 127–8
   PubMed Web of Science ®Google Scholar
• Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott P, Hutchinson IV. Genomic variation in the transforming growth factor-β1 gene. Transplantation 1998; 66: 1014–20
   PubMed Web of Science ®Google Scholar
• Border WA. Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens 1994; 3: 54–8
   PubMedGoogle Scholar
• Taniguchi Y, Yorioka N, Masaki T, Yamashita K, Ito T, Ueda H, et al. Role of transforming growth factor-beta 1 in glomerulonephritis. J Int Med Res 1997; 25: 71–80
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, et al. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154–63
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916–27
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 1996; 49: 461–9
   PubMed Web of Science ®Google Scholar
• Gant NF, Chand S, Worley RJ, Whalley PJ, Crosby UD, MacDonald PC. A clinical test useful for predicting the development of acute hypertension in pregnancy. Am J Obstet Gynecol 1974; 120: 1–7
   PubMed Web of Science ®Google Scholar
• Baker PN, Broughton PF, Symonds EM. Platelet angiotensin II binding sites in normotensive and hypertensive women. Br J Obstet Gynaecol 1991; 98: 436–40
   PubMedGoogle Scholar
• Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol 2006; 55: 130–5
   PubMed Web of Science ®Google Scholar